VivoSeq
Other

Fontan

0

Pipeline Programs↗

0

Active Trials↗

1

Companies Involved↗

Fontan is an early-stage landscape with 0 programs across 1 company. The most active players are Johnson & Johnson.

Intelligence

Pipeline Metrics

Competitive Density

0/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

75/100

Attrition Rate

23/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Johnson & Johnson logo

Johnson & Johnson

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

13

clinical trials

Completed9 · 69%
Terminated2 · 15%
Unknown status1 · 8%
Withdrawn1 · 8%

Clinical Trials

Trial Activity

13 trials

Theophylline Effects in the Fontan Circulation
Completed·OOslo University Hospital·Phase 2·NCT05717049·10 enrolled
Early Use of Vasopressin in Post-Fontan Management
Completed·MMedical College of Wisconsin·Phase 2/3·NCT03088345·20 enrolled
Pathophysiological Mechanisms of Hepatopulmonary Influence in the Fontan Circulation
Completed·UUniversity Hospital, Ghent·Phase 2·NCT00263406·40 enrolled
Sildenafil After the Fontan Operation
Completed·—·Phase 2·NCT00507819·28 enrolled
TRPV2 Agonists in the Fontan Circulation
Completed·—·Phase 4·NCT03965351·8 enrolled
Use of Vasopressin Following the Fontan Operation
Completed·WWake Forest University Health Sciences·Phase 2/3·NCT02975999·12 enrolled
Camostat Mesylate for Protein-losing Enteropathy After Fontan Operation
Completed·SSeoul National University Hospital·Phase 2·NCT05474664·19 enrolled
Home Exercise And Resiliency Training (HEART) Club: A Virtual Care at Home Program to Reduce Frailty for Adults With Fontan Circulation
Completed·UUniversity of Michigan·Preclinical·NCT05543733·53 enrolled
WE BEAT - HEART Club Fontan Wellness Project: A Virtual Resilience Promotion and Frailty Prevention Program
Completed·UUniversity of Michigan·Preclinical·NCT05199857·30 enrolled
Acute Effects of Inhaled Treprostinil in Fontan Patients
Terminated·—·Phase 2·NCT02769624·15 enrolled
An Upcoming Clinical Study to Measure the Safety and Impact of a Drug Called Macitentan in Teenage and Adult Fontan Patients.
Terminated·Johnson & Johnson logoJohnson & Johnson·Phase 3·NCT03775421·112 enrolled
Aesculus Hippocastanum L. on Fontan Circulation
Withdrawn·CCasa Espirita Terra de Ismael·Phase 2·NCT04035317
Pulmonary Capillary Recruitment in Fontan Patients
Unknown status·JJewish General Hospital·N/A·NCT04292483·15 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)